Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002194866 | SCV002357386 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004970844 | SCV005520049 | uncertain significance | Inborn genetic diseases | 2024-10-20 | criteria provided, single submitter | clinical testing | The c.2677G>A (p.A893T) alteration is located in exon 17 (coding exon 17) of the TONSL gene. This alteration results from a G to A substitution at nucleotide position 2677, causing the alanine (A) at amino acid position 893 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003923504 | SCV004743802 | likely benign | TONSL-related disorder | 2019-11-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |